DevonScottConwayMDMS

Neuroimmunology/Multiple Sclerosis

Neurology

Dr. Conway is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Neurology, 2006 - 2009
Yale-New Haven Medical CenterInternship, Internal Medicine, 2005 - 2006
Case Western Reserve University School of MedicineClass of 2005

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013

PubMed

28 citations
Interpreting change on the Symbol Digit Modalities Test in people with relapsing multiple sclerosis using the reliable change methodology.
Zachary Weinstock, Sarah A. Morrow, Devon S. Conway, Tom A. Fuchs, Curtis Wojcik
Multiple Sclerosis. 2021-10-06
19 citations
Quantifying cognition and fatigue to enhance the sensitivity of the EDSS during relapses.
Sarah A. Morrow, Devon S. Conway, Tom A. Fuchs, Curtis Wojcik, Mahmut Unverdi
Multiple Sclerosis. 2021-06-01
91 citations
Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis
Burhan Chaudhry, Jeffrey A. Cohen, Devon S. Conway
Neurotherapeutics. 2017-10-01

Effect of Tobacco Use on Disease Activity and DMT Discontinuation in Multiple Sclerosis Patients Treated with Dimethyl Fumarate or FingolimodOctober 13th, 2020
10 Ways to Fight MS FatigueDecember 18th, 2019
Gilenya's Impact on Cognitive Function and Thalamic VolumesAugust 1st, 2017